Embla Medical hf. (OTCMKTS:OSSFF – Get Free Report) is expected to post its resultson Tuesday, April 28th. Analysts expect Embla Medical hf. to post earnings of $0.0485 per share and revenue of $231.9670 million for the quarter.
Embla Medical hf. Stock Performance
Shares of OSSFF opened at $4.15 on Friday. The stock has a 50 day moving average of $4.46 and a 200-day moving average of $4.85. Embla Medical hf. has a 52 week low of $4.15 and a 52 week high of $5.33.
Embla Medical hf. Company Profile
Embla Medical hf., headquartered in Reykjavik, Iceland, develops and manufactures diagnostic medical devices for sleep, respiratory and neurophysiological monitoring. The company is publicly listed on Nasdaq Iceland and trades in the United States on the OTC market under the symbol OSSFF.
Embla Medical’s engineering and R&D teams design comprehensive solutions that combine hardware, sensors, electrodes and analysis software. Its portfolio includes ambulatory sleep assessment systems suitable for both in-lab and home-based polysomnography, as well as open-platform devices capable of capturing bioelectrical signals such as EEG, ECG and respiratory effort.
Beyond sleep diagnostics, the company’s technology supports respiratory care monitoring and neurophysiology research.
Recommended Stories
Receive News & Ratings for Embla Medical hf. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Embla Medical hf. and related companies with MarketBeat.com's FREE daily email newsletter.
